EPH151 Prevalence of Risk Factors for Serious Adverse Events Among Rheumatoid Arthritis Patients Prescribed Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors: A Merative Marketscan Cross-Sectional Study
Abstract
Authors
J.C. Janak R. Ross B. Brady L.A. Palmer J.F. Baker